Vaccine Center News
School of Medicine researcher awarded $1.25 million grant to study immune response to cancer
Emory Professor Retires, Leaves Legacy of Malaria Advances to Improve Global Health
25 Early Career Scientists Become HHMI Hanna Gray Fellows
Cheryl Day to Direct AIDS Clinical Trials Group (ACTG) Network as Lab Director for Immunology Specialty Laboratory (ISL)
COVID-19 survivors may possess wide-ranging resistance to the disease
News from the Emory School of Medicine
Moderna COVID-19 Vaccine appears safe, shows signs of working in older adults: study
Could a Mask be a Crude Vaccine? (NYT)
Genomics Core Will Help Predict COVID-19 Severity
Why Flu Vaccines Don't Protect People for Long
Phase 3 COVID-19 Clinical Trial Launch
Genomics Research Will Help Predict COVID-19 Disease Severity, Inform Treatment Decisions
COVID-19 vaccine tested at Emory is safe, generates immune response, early results show
An mRNA Vaccine Against SARS-CoV-2 Promising Preliminary Results
Vaccine additives can enhance immune flexibility, with implications for flu and SARS-CoV-2
Defining CD8+ T Cells that Provide the Proliferative Burst after PD-1 Therapy (Rafi Ahmed + others)
Harnessing Stem Cell-Like T Cells to Fight Cancer Better (Rafi Ahmed + others)
HIV pre-exposure drug regimen tested at Emory highly effective in preventing infection, study says
CNN Interviews Carlos del Rio, MD Re: Spike in COVID-19 Cases
CNN Interviews Carlos del Rio, MD Re: Georgia Summer Camp COVID-19 Cases
Carlos del Rio Interviewed Re: Early Positive COVID-19 Vaccine Results (CNBC)
Carlos del Rio and John Lewin on Fox News Re: Spike in COVID-19 Cases
Emory Researchers Find T Cell Responses Key for Controlling Asymptomatic TB
The Race for a COVID-19 Vaccine Featuring Nadine Rouphael, MD
New Adjuvant Successful in Extending Immunity Against HIV
Comprehensive List of Emory University COVID-19 Work
Dr. Marconi Quoted Re: Eli Lilly Study Launch for COVID-19
Herd Immunity (Associated Press) EVC Faculty Quoted
Shutting down may have prevented 60 million infections (Carlos del Rio on CNN)
T cell-inducing vaccine durably prevents mucosal SHIV infection (Nature Article)
COVID-19 Death Count Predictions EVC Faculty Quoted (ABC News)
NIAID Grant to Develop COVID-19 Vaccine
Moderna Update CNN Featuring Dr. Carlos del Rio
Dr. Wrammert & Dr. Suthar COVID-19 Work in 11 Alive News
Combination Treatment for COVID-19 Patients-Dr. Marconi quoted
Inflammation in Severe COVID-19 CNN
Antibody Response in Acute COVID Patients-FOX 5
Types of COVID-19 Tests & What They Tell Us
NBC News Featuring Mehul Suthar and COVID-19 Immunity
Dr. Carlos del Rio on how this pandemic was never "like the flu"
Dr. Aneeth Mehta-Combining two drugs for COVID-19 Patients
A Glimmer of Hope with Dr. Aneesh Mehta (COVID-19)
What to know about potential COVID-19 vaccines
Immunotherapy Combo Achieves Reservoir Shrinkage in HIV Model
Our public health experts weigh in on opening states back up
In animal models, a 'shocking' step toward a potential HIV cure
New HIV Vaccine Combination Strategy Provides Better and More Durable Protection
Clinical Trial Participants are Helping to Find Solutions
Clinical Trials Underway NBC News
Newly Launched Study on COVID-19 Immune Response
EVC Helps Lead remdesivir Study
New COVID-19 Data Showing First Cases in GA in January
What COVID-19 Testing Can and Can't Tell Us
Blood Clotting Factor in COVID-19 Patients
New Funding to Better Understand COVID-19 at EVC
Dr. Carlos del Rio on CNN- COVID-19 Vaccine Trial Update
MIT Enterprise Forum Video on COVID-19 with Dr. Rama Amara
New COVID-19 Testing at Emory Hospital